CGRP antagonists (SmithKline Beecham)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCGRP antagonists (SmithKline Beecham)
Drug Alias NameSB-(+)-273779SB-273779
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcitonin gene-related peptide receptor antagonists
TargetsCalcitonin gene-related peptide receptor
Therapy Area/IndicationsInflammationDiabetes Mellitus, Type 2Migraine Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSmithkline Beecham Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSmithkline Beecham Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes Mellitus, Type 2Migraine Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A